- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 247
JD Health jets towards IPO
JD.com’s healthcare spinoff has filed for an initial public offering after raising more than $1.9bn in equity funding from investors including Hillhouse Capital and Citic Capital.
Sep 30, 2020KKday books up $75m series C
Alibaba, HIS and Line have all previously backed KKday, an online travel experience provider with more than 5 million registered users.
Sep 30, 2020Inspiration Capital sparks $73m fund
Hexing Electrical, CSD Environment, Hailang Group and SIG are among the limited partners in a $73m fund raised by Qiming spinoff Inspiration Capital.
Sep 30, 2020Inspiration Capital sparks $73m fund
Shanghai Jiao Tong University is among the limited partners in a $73m fund raised by Qiming spinoff Inspiration Capital.
Sep 30, 2020SF Holdings helps package $308m fund
SF Holdings has joined forces with Citic Capital’s CCRE China Logistics to form a $308m fund that will focus on the logistics sector.
Sep 29, 2020Logicreation thinks through $152m IPO
Tencent and Heyi Group are among the investors in line for an exit as Logicreation files to go public in China.
Sep 29, 2020New Ruipeng picks up funding
Tencent has led a round worth hundreds of millions of dollars for New Ruipeng, which is now valued at $4.4bn and also backed by Boehringer Ingelheim and Country Garden.
Sep 29, 2020XtalPi calculates $319m series C
SoftBank Vision Fund 2, PICC Group and Morningside Venture Capital co-led the round, which also attracted Tencent, China Life Insurance, SIG China and others.
Sep 28, 2020Tencent helps transfer $176m to Taimei
Tencent joined GL Ventures and YF Capital to co-lead a $176m funding round for Taimei Technology, while SoftBank China Venture Capital also invested.
Sep 28, 2020InventisBio ignites $147m series D
Lilly Asia Ventures has returned for a $147m series D round that will allow InventisBio to advance its treatments for breast cancer and gout into phase 2 clinical trials.
Sep 28, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


